基金大事件|ETF迎史上最大单次分红！公募基金总规模突破33万亿元！

Group 1: ETF Market Developments - The largest ETF in the market, Huatai-PB CSI 300 ETF, announced a cash dividend exceeding 8 billion yuan, setting a record for the largest single dividend in ETF history [2] - Public fund dividends have surged this year, with total dividends exceeding 95 billion yuan, a year-on-year increase of over 50%, and index funds contributing over 20 billion yuan [2] - The bond ETF market has reached a significant milestone, surpassing 300 billion yuan in total scale, with nearly 10 bond ETFs exceeding 10 billion yuan [6] Group 2: Innovation Drug Sector - The innovation drug sector in Hong Kong has seen a remarkable increase, with some stocks rising over 60% this year, leading to record trading volumes and turnover rates exceeding 100% [2][3] - A major Chinese biopharmaceutical company is in discussions with several multinational pharmaceutical companies for significant licensing deals, indicating strong growth potential in the sector [6] Group 3: Public REITs and Fund Performance - Public REITs have experienced a "one-day sell-out" phenomenon, indicating strong investor interest and demand [10][11] - The first "doubling fund" of the year has emerged, driven by the strong performance of innovation drug sector funds, with some funds reporting over 100% returns [7] Group 4: Regulatory Actions - The Shandong Securities Regulatory Bureau has taken administrative measures against Lide Capital Management, indicating ongoing regulatory scrutiny in the financial sector [8]